Device specific quality of life in subcutaneous versus transvenous implantable cardioverter defibrillator implantations: results from the ATLAS multi-centre randomized controlled trial
25 August 2023 (07:30 - 18:30)
Organised by: 

About the speaker

McMaster University, Hamilton (Canada)
3 More presentations in this session
Assistant Professor Y. Tsai (Taoyuan, TW)
Doctor F. Ecarnot (Besancon, FR)
Access the full session
The Event
ESC Congress 2023
25 August - 28 August 2023
You may be interested in
Congress Session

